Chiesi Group

Chiesi Group to acquire Zymenex

Tuesday, August 27, 2013

Chiesi Group, a European pharmaceutical company, has agreed to acquire Danish biopharmaceutical company Zymenex and its related group of companies, a biopharmaceutical group focused on R&D of biologic therapeutics for the treatment of rare and life threatening genetic diseases. Terms of the transaction were not disclosed.

[Read More]